Last reviewed · How we verify

NCT06001164

Double-bundle Versus Single-Bundle Anterior Cruciate Ligament Reconstruction

Completed NA Last updated 21 August 2023
What this trial tests

NA trial testing ACL reconstruction: Double bundle in ACL Injury in 153 participants. Completed in 30 September 2022.

Timeline
6 April 2021
Primary endpoint
30 September 2022
30 September 2022

Quick facts

Lead sponsorTampere University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment153
Start date6 April 2021
Primary completion30 September 2022
Estimated completion30 September 2022
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Tampere University Hospital

Who can join

Eligibility, any sex, with ACL Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare double-bundle and single-bundle techniques for ACL reconstruction in a long-term 15-year follow-up. Our hypothesis is that the DB technique is better than the SB technique.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Double-bundle anterior cruciate ligament reconstruction resulted in better International Knee Documentation Committee objective grading at fifteen year follow-up compared to single-bundle reconstruction.
    Seppänen A, Suomalainen P, Kiekara T, Mäenpää H, et al · · 2024 · cited 7× · PMID 38337046 · DOI 10.1007/s00264-024-06106-7

Verify or expand the search:

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

Other Tampere University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06001164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing